Zeltia Company Profile

Aggregated data from the web about Zeltia

Company Name	Zeltia
Website
Snippet	PharmaMar provides you all the financial information possible regarding our activities on the BME exchange, historical quarterly and annual information.
Defunct	2015 (2015)
Founded	1939
Revenue	US$176,000,000 (2009)
Website	www.zeltia.com
Industry	Pharmaceutical
Products	Pharmaceuticals
Traded as	BMAD: ZEL
Key people	Jos茅 Fern谩ndez Sousa-Faro (Chairman)
Net income	(US$40.3 million) (2009)
Area served	Worldwide
Former type	Sociedad An贸nima
Headquarters	Madrid, Spain
Subsidiaries	PharmaMar, Gen贸mica, Sylentis, Zelnova, Xylazel
Total assets	US$302.9 million (2009)
Total equity	US$59 million (2009)
Operating income	(US$46.3 million) (2009)

Zeltia is part of the Spain company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that 17吃瓜网 does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.